We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATY icon
226
Cathay General Bancorp
CATY
$4.22B
$4.02M 0.1%
+142,630
New +$4.22M
RHP icon
227
Ryman Hospitality Properties
RHP
$8.43B
$4.01M 0.1%
79,158
-190
-0.2% -$9.63K
INVX
228
Innovex International
INVX
$1.96B
$3.97M 0.1%
67,910
+9,060
+15% +$548K
RYAM icon
229
Rayonier Advanced Materials
RYAM
$604M
$3.89M 0.1%
+286,545
New +$3.51M
NSC icon
230
Norfolk Southern
NSC
$75.4B
$3.89M 0.1%
45,691
-51
-0.1% -$4.33K
PRXL
231
DELISTED
Parexel International Corp
PRXL
$3.86M 0.1%
61,367
+14,711
+32% +$910K
SYK icon
232
Stryker
SYK
$125B
$3.86M 0.1%
32,190
+165
+0.5% +$18.4K
LMT icon
233
Lockheed Martin
LMT
$134B
$3.78M 0.09%
15,228
-879
-5% -$207K
VFC icon
234
VF Corp
VFC
$5.63B
$3.77M 0.09%
65,090
-6,835
-10% -$404K
AGN
235
DELISTED
Allergan plc
AGN
$3.72M 0.09%
16,103
+455
+3% +$105K
WNC icon
236
Wabash National
WNC
$512M
$3.71M 0.09%
+292,440
New +$3.93M
PEP icon
237
PepsiCo
PEP
$190B
$3.69M 0.09%
34,843
-2,556
-7% -$264K
IBM icon
238
IBM
IBM
$211B
$3.67M 0.09%
25,322
+5,503
+28% +$788K
GVI icon
239
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
$3.65M 0.09%
32,190
-1,898
-6% -$213K
SRCE icon
240
1st Source
SRCE
$2.16B
$3.61M 0.09%
+111,390
New +$3.68M
DCOM
241
DELISTED
Dime Community Bancshares
DCOM
$3.56M 0.09%
+209,360
New +$3.7M
FRME icon
242
First Merchants
FRME
$2.68B
$3.5M 0.09%
+140,310
New +$3.49M
ZTS icon
243
Zoetis
ZTS
$32.4B
$3.41M 0.09%
71,890
+10,150
+16% +$480K
NWL icon
244
Newell Brands
NWL
$2.38B
$3.39M 0.08%
69,888
-236,675
-77% -$11.1M
XPRO icon
245
Expro Ltd
XPRO
$1.79B
$3.39M 0.08%
38,664
-1,304
-3% -$124K
CB icon
246
Chubb
CB
$135B
$3.38M 0.08%
25,861
+206
+0.8% +$25.4K
GSBC icon
247
Great Southern Bancorp
GSBC
$874M
$3.34M 0.08%
90,434
-280
-0.3% -$10.7K
ORCL icon
248
Oracle
ORCL
$374B
$3.08M 0.08%
75,152
-8,880
-11% -$355K
ACM icon
249
Aecom
ACM
$9.3B
$2.99M 0.07%
94,093
+79,318
+537% +$2.51M
MUB icon
250
iShares National Muni Bond ETF
MUB
$45.1B
$2.97M 0.07%
26,071
-5,520
-17% -$621K
8 9
10
11 12

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.